Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

Lancet

Volumn 351, Issue 9112, 1998, Pages 1320-1325

  Calarota, Sandra ^a   Bratt, Göran ^b   Nordlund, Siv ^a   Hinkula, Jorma ^a   Leandersson, Ann Charlotte ^a   Sandström, Eric ^b   Wahren, Britta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; VACCINATION; VIRUS IMMUNITY;

EID: 17444435761     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09440-3     Document Type: Article

References (35)

1. 1 Johnson RP, Walker BD. Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural proteins. Curr Top Microbiol Immunol 1994; 189: 35-63.
2. 2 Koup RA, Pikora CA, Luzuriaga K, et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantification of effector cell populations with p17 and p24 specificities. J Exp Med 1991; 174: 1593-1600.
3. 3 Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK. High frequency of memory and effector gag-specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol 1990; 2: 707-12.
4. 4 Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, et al. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-I proteins. AIDS 1992; 6: 1249-58.
5. 5 Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HW-1 infection: differential CTL responses to HW-1 and Epstein-Barr virus in late disease. J Exp Med 1993; 177: 249-56.
6. 6 van Baalen CA, Klein MR, Geretti AM, et al. Selective in vitro expansion of HLA class-I-restricted HIV-1 gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 1993; 7: 781-86.
7. 7 Moss PAH, Rowland-Jones SL, Frodsham PM, et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci USA 1995; 92: 5773-77.
8. 8 Geretti AM, Dings MEM, van Els CACM, et al. Human immunodeficiency virus type 1 (HIV-1)-and Epstein-Barr virus-specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1-infected persons. J Infect Dis 1996; 174: 34-45.
9. 9 Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3: 212-17.
10. 10 Rowland-Jones S, Tan R, McMichael A. Role of cellular immunity in protection against HIV infection. Adv Immunol 1997; 65: 277-346.
11. 11 Hydenburg-Fuller D, Haynes JR. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res Hum Retroviruses 1994; 10: 1433-41.
12. 12 Wang B, Boyer J, Srikantan V, et al. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol 1993; 12: 799-805.
13. 13 Boyer JD, Ugen KE, Wang B, et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997; 3: 525-32.
14. 14 Yasutomi Y, Robinson HL, Lu S, et al. Simian immunodeficiency virus specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 1996; 70: 678-81.
15. 15 Wahren B, Hinkula J, Ljungdahl Ståhle E, Borrebaeck CAK, Schwartz S, Wigzell H. Nucleic acid vaccination with HIV regulatory genes. Ann N Y Acad Sci 1995; 772: 278-81.
16. 16 Hinkula J, Svanholm C, Schwartz S, et al. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J Virol 1997; 71: 5528-39.
17. 17 Hinkula J, Lundholm P, Wahren B. Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine 1997; 15: 874-78.
18. 18 Asakura Y, Hamajima K, Fukushima J, Mohri H, Okubo T, Okuda K. Induction of HIV-1 nef-specific cytotoxic T lymphocytes by nef-expressing DNA vaccine. Am J Hemtol 1996; 53: 116-17.
19. 19 Spector DH, Wade E, Wright DA, et al. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol 1990; 64: 2298-308.
20. 20 Kavanaugh MP, Miller DG, Zhang W, et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91: 7071-75.
21. 21 Ljunggren HG, Kärre K. Host resistant directed selectively against H-2-deficient lymphoma variants. J Exp Med 1985; 162: 1745-59.
22. 22 Lubaki MN, Egan MA, Siliciano RF, Weinhold KJ, Bollinger RC. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res Hum Retroviruses 1994; 10: 1427-31.
23. 23 Strijbosch LWG, Does RJMM, Buurman WA. Computer aided design and evaluation of limiting and serial dilution experiments. Int J Biomed Comput 1988; 23: 279-90.
24. 24 Wahren B, Bratt G, Persson C, et al. Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp 160. J Acquir Immune Defic Syndr Hum Retrovirol 1994; 7: 220-29.
25. 25 Leandersson A-C, Bratt G, Hinkula J, et al. Induction of specific T-cell responses in HIV infection. AIDS (in press).
26. 26 Ratto S, Sitz KV, Scherer AM, et al. CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop. J AIDS Human Retrovirol 1996; 11; 128-36.
27. 27 Riviere Y, Robertson MN, Buseyne F. Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes. Curr Top Microbiol Immunol 1994; 189: 65-74.
28. 28 Woods TC, Roberts BD, Butera ST, Folks TM. Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood 1997; 89: 1635-41.
29. 29 Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS. Structure and expression of tat-, rev-and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol 1990; 64: 3391-98.
30. 30 Zhong Q, Nakaya T, Tateno Y, et al. A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci. Vaccine 1997; 15: 497-510.
31. 31 Shugars D, Smith MS, Glueck DH, Nantermet PV, Seillier-Moiseiwitsch F, Swanstrom R. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol 1993; 67: 4639-50.
32. 32 Cullen BR. Mechanism of action of regulatory protein encoded by complex retroviruses. Microbiol Rev 1992; 56: 375-94.
33. 33 Lamhamedi-Cherradi S. Culmann-Penciolelli B, Guy B, et al. Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 1995; 9: 421-26.
34. 34 van Baalen CA, Pontesilli O, Huisman RC, et al. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J Gen Virol 1997; 78: 1913-18.
35. 35 Cease KB. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu Rev Immunol 1994; 12: 923-89.